Case Reports
Parotid gland arteriovenous malformation embolisation A novel
approach to the use of precipitating hydrophobic injectable liquid
(PHIL)
Author(s): Aigars Lacis*, Karlis Kupcs, Janis Savlovskis and Helmuts Kidikas
Arteriovenous malformations (AVMs) develop due to a failure of
differentiation in the early stages of embryogenesis. AVMs are characterised
by an abnormal connection between feeding arteries and draining veins by
an intervening of pathologic blood vessels network (nidus). The bypassing
of the capillary system results in high-flow arteriovenous blood shunting.
AVM of the parotid gland (PG) is an extremely rare condition with very
few reported cases in the literature. Treatment options include embolisation,
laser, cryotherapy, corticosteroids and the surgical resection of the PG. Embolisation using a wide variety of liquid embolic agents (LEAs) plays a key
role in the treatment of PG AVM. The novel use of an iodinated copolymer-
based precipitating hydrophobic injectable liquid (PHIL) for trans-arterial
embolisation of PG AVM is safe, feasible and effective... Read More»
DOI:
10.37532/1983-8905.2021.14(1).1-3
+441704335730
